TELO 8-K: Contract win
Telomir Pharmaceuticals
Filed with the SEC on · accession 0001493152-26-052994
TELO filed a 8-K (current report) with the SEC on Nov 18, 2026. Telomir Pharmaceuticals announced it selected Linical, a global contract research organization, to support its FDA-cleared Phase 1/2 clinical trial of Telomir-Zn in patients with advanced or metastatic triple-negative breast cancer.
Summary of the filing
Telomir Pharmaceuticals announced it selected Linical, a global contract research organization, to support its FDA-cleared Phase 1/2 clinical trial of Telomir-Zn in patients with advanced or metastatic triple-negative breast cancer. The company executed a Master Services Agreement and clinical trial Work Order with Linical, targeting clinical initiation in the first quarter of 2027.
Key details
✦ Ask GOAX AI about this filing — what it means for TELO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TELO?
Click hereFrequently asked questions
What did TELO file with the SEC on Nov 18, 2026?
TELO filed a 8-K (Contract win). Telomir Pharmaceuticals announced it selected Linical, a global contract research organization, to support its FDA-cleared Phase 1/2 clinical trial of Telomir-Zn in patients with advanced or metastatic triple-negative breast cancer. The company executed a Master Services Agreement and clinical trial Work Order with Linical, targeting clinical initiation in the first quarter of 2027.
What does a contract win mean for TELO stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other TELO SEC filings
- 10-Q · SEC filingNov 6, 2026
- 424B3 · Secondary offeringNov 5, 2026
- EFFECT · Shelf registrationNov 5, 2026
- S-3 · Shelf registrationOct 27, 2026
- 8-K · Secondary offeringOct 6, 2026
- 8-K · Fda approvalSep 17, 2026
- 8-K · Board changeSep 16, 2026
- 8-K · Fda approvalSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
Get alerts when TELO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days